[1]
Tha?i, D., Blauvelt, A., Reich, K., Warren, R., Piguet, V., Brock, F., Fierens, F., Ciaravino, V. and Lebwohl, M. 2021. Long-Term Improvements in Health-Related Quality of Life of Patients with Moderate to Severe Plaque Psoriasis Treated with Certolizumab Pegol: Results from the CIMPASI-1 and CIMPASI-2 Phase 3 Trials. SKIN The Journal of Cutaneous Medicine. 5, 1 (Jan. 2021), s20. DOI:https://doi.org/10.25251/skin.5.supp.20.